32 results
8-K
EX-2.1
TXMD
TherapeuticsMD Inc
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
of severance for a termination without cause or (B) provides for payments upon a change-in-control of the Company;
(viii)any collective bargaining Contract … applicable Laws respecting employment and employment practices, including (without limitation) terms and conditions of employment, collective bargaining, equal
8-K
EX-10.00
TXMD
TherapeuticsMD Inc
7 Apr 10
Entry into a Material Definitive Agreement
12:00am
Subsidiary is a party to any collective bargaining agreement or employs any member of a union. No Executive Officer of the Company (as defined in Rule 501(f
8-K
EX-10.01
TXMD
TherapeuticsMD Inc
22 Dec 10
Entry into a Material Definitive Agreement
12:00am
to any collective bargaining agreement or employs any member of a union. No Executive Officer of the Company (as defined in Rule 501(f
8-K
EX-4.1
TXMD
TherapeuticsMD Inc
2 Oct 12
Therapeuticsmd, Inc. Announces $8.5 Million Private Placement
12:00am
to such employee’s relationship with the Company or its Subsidiary, and neither the Company nor its Subsidiary a party to a collective bargaining agreement
8-K
EX-10.01
jd87 4qssowkb4eu6
21 Jul 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
ep9a6qdcum4u skidx
15 Dec 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
x8cqud1djb
25 Jan 13
Special Note Regarding Forward-Looking Statements
12:00am
8-K
knb4jy
11 Oct 11
Entry into a Material Definitive Agreement
12:00am
8-K/A
uy8n5xr0oht9
22 Nov 11
Entry into a Material Definitive Agreement
12:00am
SC TO-T
EX-99
k6bjfc3
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-2.1
h90zihh
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
424B5
v831r3gw8miuorh
7 Mar 13
Prospectus supplement for primary offering
12:00am
424B5
6on4w
15 Mar 13
Prospectus supplement for primary offering
12:00am